HROW HARROW, INC.

Nasdaq harrowinc.com


$ 40.64 $ 2.90 (7.65 %)    

Friday, 14-Nov-2025 15:54:42 EST
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 40.79
$ 36.95
$ 40.57 x 350
$ 40.69 x 1
$ 37.13 - $ 41.31
$ 20.85 - $ 50.72
771,542
na
1.51B
$ 1.23
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-27-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-19-2024 12-31-2023 10-K
9 11-13-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-23-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-10-2022 12-31-2021 10-K
17 11-09-2021 09-30-2021 10-Q
18 08-10-2021 06-30-2021 10-Q
19 05-11-2021 03-31-2021 10-Q
20 03-08-2021 12-31-2020 10-K
21 11-09-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-11-2020 03-31-2020 10-Q
24 03-13-2020 12-31-2019 10-K
25 11-13-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 03-12-2019 12-31-2018 10-K
29 11-13-2018 09-30-2018 10-Q
30 08-06-2018 06-30-2018 10-Q
31 05-15-2018 03-31-2018 10-Q
32 03-08-2018 12-31-2017 10-K
33 11-14-2017 09-30-2017 10-Q
34 08-10-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 03-21-2017 12-31-2016 10-K
37 11-14-2016 09-30-2016 10-Q
38 08-15-2016 06-30-2016 10-Q
39 05-12-2016 03-31-2016 10-Q
40 03-23-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ladenburg-thalmann-maintains-buy-on-harrow-raises-price-target-to-66

Ladenburg Thalmann analyst Jeffrey Cohen maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $64 to $66.

 hc-wainwright--co-maintains-buy-on-harrow-raises-price-target-to-69

HC Wainwright & Co. analyst Yi Chen maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $64 to $69.

 b-riley-securities-reiterates-buy-on-harrow-raises-price-target-to-74

B. Riley Securities analyst Mayank Mamtani reiterates Harrow (NASDAQ:HROW) with a Buy and raises the price target from $70 t...

 lake-street-maintains-buy-on-harrow-raises-price-target-to-70

Lake Street analyst Thomas Flaten maintains Harrow (NASDAQ: HROW) with a Buy and raises the price target from $42 to $70.

 hc-wainwright--co-reiterates-buy-on-harrow-maintains-64-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Harrow (NASDAQ: HROW) with a Buy and maintains $64 price target.

 btig-reiterates-buy-on-harrow-maintains-63-price-target

BTIG analyst Thomas Shrader reiterates Harrow (NASDAQ: HROW) with a Buy and maintains $63 price target.

 could-harrows-new-sedation-pill-change-millions-of-medical-procedures-forever

Harrow, Inc. (NASDAQ: HROW), a U.S.-based provider of ophthalmic disease management solutions, announced on Friday that it has ...

 harrow-to-acquire-melt-pharma-advancing-sublingual-sedation-therapy-melt-300-toward-2027-nda-after-positive-phase-3-results

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it ...

 b-riley-securities-maintains-buy-on-harrow-raises-price-target-to-70

B. Riley Securities analyst Mayank Mamtani maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $65 to...

 craig-hallum-maintains-buy-on-harrow-raises-price-target-to-64

Craig-Hallum analyst Chase Knickerbocker maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $54 to $64.

 btig-maintains-buy-on-harrow-raises-price-target-to-63

BTIG analyst Thomas Shrader maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $62 to $63.

 hc-wainwright--co-maintains-buy-on-harrow-raises-price-target-to-64

HC Wainwright & Co. analyst Yi Chen maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $60 to $64.

 harrow-fy2025--revenue-expected-to-be-more-than-280000m-vs-283545m-est

Harrow (NASDAQ:HROW) FY2025 Revenue expected to be more than $280.000M vs $283.545M Est

 harrow-q2-adj-eps-024-beats-001-estimate-sales-63742m-miss-65234m-estimate

Harrow (NASDAQ:HROW) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.01 by 2081....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION